Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 76 clinical trials
Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices

This phase II trial studies how well smoking cessation treatment plans work in tobacco-dependent cancer patients when delivered virtually as part of their cancer care in community oncology practices. Virtual information and counseling sessions may help cancer patients quit smoking.

primary cancer
cancer care
Accepts healthy volunteers
cancer
smoking cessation
  • 5 views
  • 23 Mar, 2022
  • 32 locations
FDG and FDOPA PET Demonstration of Functional Brain Abnormalities

information to distinguish recurrent tumors from treatment-induced radiation changes in patients with treated brain neoplasms. This is important for improving patient outcomes by allowing treating physicians

temozolomide
MRI
brain tumor
recurrent tumor
  • 9 views
  • 02 Mar, 2022
  • 1 location
Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276

tissues. This study will evaluate the side effects and effective doses of 4SCAR-276 in treating refractory and/or recurrent tumors.

solid tumor
neutrophil count
platelet count
serum bilirubin
kidney function test
  • 0 views
  • 24 Jan, 2021
  • 2 locations
ACTengine® IMA203 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors (ACTengine)

The study purpose is to establish the safety and tolerability of IMA203 product with or without combination with nivolumab in patients with solid tumors that express preferentially expressed antigen in melanoma (PRAME).

carcinoma
cirrhosis
alopecia
metastatic malignant solid tumor
solid tumour
  • 0 views
  • 06 Jun, 2022
  • 6 locations
Selumetinib and Olaparib in Solid Tumors

cancer that has a certain type of genetic mutation (change). It is considered investigational to use selumetinib in combination with olaparib to treat advanced or recurrent cancer. The study

measurable disease
mammogram
KRAS
  • 11 views
  • 26 Mar, 2022
  • 1 location
Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma

effective medical therapy. Repeat surgery or radiation therapy may be possible, but they are temporizing measures with limited durable relief. PD-L1 expression in meningioma is increased for recurrent

recurrent meningioma
neutrophil count
blood transfusion
definitive radiation therapy
intracranial meningioma
  • 108 views
  • 04 Mar, 2022
  • 1 location
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

patients with ultra-high-risk pediatric solid tumors with minimal disease burden, as defined in the inclusion criteria below, can prevent and/or slow recurrent tumor formation in pediatric solid tumors and

filgrastim
karnofsky performance status
kidney function tests
platelet count
desmoplastic
  • 0 views
  • 12 Mar, 2022
  • 1 location
Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel for Recurrent Glioblastoma (SC9/ABX)

surgical resection of the recurrent tumor. During that procedure and when feasible, a first test dose of the chemotherapy will be administered in the operating room after sonication (procedure of

corticosteroids
contrast-enhanced magnetic resonance imaging
recurrent glioblastoma
glioblastoma multiforme
recurrent tumor
  • 25 views
  • 14 Jun, 2022
  • 1 location
A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer

recurrent tumor is identified and a TURBT (transurethral resection of a bladder tumor) or biopsy procedure is performed to remove it.

neutrophil count
transurethral resection
gemcitabine
bladder tumor
invasive bladder cancer
  • 0 views
  • 10 May, 2022
  • 7 locations
Lorlatinib Combinations in Lung Cancer

This research study is evaluating Lorlatinib in combination with Crizotinib, Binimetinib, or TNO155 as a possible treatment for either anaplastic lymphoma kinase (ALK)-positive lung cancer or ROS1-positive lung cancer. This research study involves four study drugs. Lorlatinib Binimetinib Crizotinib TNO155

lorlatinib
lung carcinoma
progressive disease
lung cancer
proto-oncogene tyrosine-protein kinase ros
  • 0 views
  • 19 Mar, 2021